Regenerative Medical Technology Group Inc. (RMTG) › Shareholders' EquityRegenerative Medical Technology Group Inc. (RMTG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$5.51M2017: -$2.56M2018: -$4.54M2019: -$7.36M2020: -$6.41M2021: -$6.76M2022: -$11.98M2023: -$21.80M2024: -$27.36M2025: -$34.75M-$34.75M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$34.75M-27.0%2024-$27.36M-25.5%2023-$21.80M-81.9%2022-$11.98M-77.3%2021-$6.76M-5.4%2020-$6.41M+12.9%2019-$7.36M-62.1%2018-$4.54M-77.2%2017-$2.56M+53.5%2016-$5.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share